Role of the JDCC. Without limiting any of the foregoing, subject to Section 2.1.3, the JDCC will perform the following functions, some or all of which may be addressed directly at any given JDCC meeting: (i) Supervise the activities under the Strategic Plan, including reviewing updates to the key elements of the planning and strategy to support Development, Manufacturing, Regulatory Approvals and Commercialization; (ii) establish teams, committees and working groups to oversee and manage activities under the Strategic Plan; (iii) receive updates from Novartis regarding any CMO Agreements and strategic sublicenses granted by Novartis to Third Parties in Major Markets as contemplated by Section 5.2.1; (iv) if regulatory or Development issues arise that are outside of Novartis’ reasonable control that impede achievement of any Specific Performance Milestone Event on the stated timeline, discuss in good faith and revise the date by which the applicable Specific Performance Milestone Event will be or can be achieved as contemplated by Section 6.4.2; (v) assisting with and participating in the resolution of disputes as contemplated in Section 13.1; and (vi) such other review and advisory responsibilities as may be assigned to the JDCC by the Parties pursuant to this Agreement.
Appears in 4 contracts
Samples: Strategic Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc), Strategic Collaboration, Option and License Agreement (Akcea Therapeutics, Inc.), Strategic Collaboration, Option and License Agreement (Akcea Therapeutics, Inc.)